Page last updated: 2024-08-22

sizofiran and Uterine Neoplasms

sizofiran has been researched along with Uterine Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, Y1
Chen, JT; Hasumi, K; Masubuchi, K; Shimizu, Y; Suzuki, M; Teshima, H1
Date, Y; Iwanari, O; Kijima, S; Kitao, M; Miyako, J; Moriyama, M; Ryuko, K; Yoshino, N1

Reviews

1 review(s) available for sizofiran and Uterine Neoplasms

ArticleYear
[Phase III study of gynecologic cancer in Japan].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9

    Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combinations; Female; Genital Neoplasms, Female; Humans; Japan; Multicenter Studies as Topic; Ovarian Neoplasms; Sizofiran; Survival Analysis; Tegafur; Uracil; Uterine Neoplasms

2002

Other Studies

2 other study(ies) available for sizofiran and Uterine Neoplasms

ArticleYear
[Sizofiran and recombinant interferon gamma stimulate peritoneal macrophages obtained from patients with gynecologic malignancies--increased secretion of tumor necrosis factor, IL-1 and interferon-gamma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:7

    Topics: Dinoprostone; Female; Glycosaminoglycans; Humans; Interferon-gamma; Interleukin-1; Macrophage Activation; Ovarian Neoplasms; Peritoneal Cavity; Recombinant Proteins; Sizofiran; Tumor Necrosis Factor-alpha; Uterine Neoplasms

1990
[The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation].
    Nihon Gan Chiryo Gakkai shi, 1989, Oct-20, Volume: 24, Issue:10

    Topics: Adult; Aged; Combined Modality Therapy; Female; Glycosaminoglycans; Humans; Middle Aged; Sizofiran; Uterine Neoplasms

1989